MDxHealth SA ROE 2018-2025 | MDXH

Current and historical return on equity (ROE) values for MDxHealth SA (MDXH) over the last 10 years. Return on equity can be defined as the amount of net income returned as a percentage of shareholders equity. Return on equity measures a corporation's profitability by revealing how much profit a company generates with the money shareholders have invested.
MDxHealth SA ROE - Return on Equity Historical Data
Date TTM Net Income Shareholder's Equity Return on Equity
2025-03-31 $-0.04B $0.01B -537.93%
2024-12-31 $-0.04B $0.02B -709.09%
2024-09-30 $-0.04B $0.02B -1228.57%
2024-06-30 $-0.04B $-0.01B -1120.00%
2024-03-31 $-0.04B $0.00B -683.33%
2023-12-31 $-0.04B $0.01B -279.37%
2023-06-30 $-0.04B -389.47%
Sector Industry Market Cap Revenue
Medical Medical Information Systems $0.103B $0.090B
MDxHealth SA is a healthcare company which provides actionable molecular diagnostic information for diagnosis and treatment of cancer. The company's tests are based on proprietary gene methylation and other molecular technologies and assist physicians with the diagnosis of cancer. MDxHealth SA is headquartered in Herstal, Belgium.
Stock Name Country Market Cap PE Ratio
Veeva Systems (VEEV) United States $46.023B 58.55
Doximity (DOCS) United States $11.285B 52.24
Hims & Hers Health (HIMS) United States $11.252B 116.91
Tempus AI (TEM) United States $10.318B 0.00
IRhythm Technologies (IRTC) United States $4.301B 0.00
Inspire Medical Systems (INSP) United States $4.107B 64.17
Hinge Health (HNGE) United States $3.444B 0.00
Privia Health (PRVA) United States $2.573B 175.83
Enovis (ENOV) United States $2.053B 11.45
Phreesia (PHR) United States $1.706B 0.00
Schrodinger (SDGR) United States $1.593B 0.00
Azenta (AZTA) United States $1.563B 72.66
10x Genomics (TXG) United States $1.554B 0.00
Clover Health Investments (CLOV) United States $1.552B 0.00
Omnicell (OMCL) United States $1.395B 24.60
Evolent Health (EVH) United States $1.318B 112.30
Claritev (CTEV) United States $0.783B 0.00
Fulgent Genetics (FLGT) United States $0.595B 0.00
Standard BioTools (LAB) United States $0.513B 0.00
Veradigm (MDRX) United States $0.498B 0.00
Butterfly Network (BFLY) United States $0.462B 0.00
Talkspace (TALK) United States $0.460B 137.50
Outset Medical (OM) United States $0.365B 0.00
TruBridge (TBRG) United States $0.345B 765.33
Health Catalyst (HCAT) United States $0.278B 0.00
Nyxoah SA (NYXH) Belgium $0.264B 0.00
SOPHiA GENETICS SA (SOPH) Switzerland $0.250B 0.00
KORU Medical Systems (KRMD) United States $0.172B 0.00
American Well (AMWL) United States $0.131B 0.00
EUDA Health Holdings (EUDA) Singapore $0.119B 0.00
Pulmonx (LUNG) United States $0.107B 0.00
CareCloud (CCLD) United States $0.102B 3.90
Zepp Health (ZEPP) Netherlands $0.088B 0.00
Insight Molecular Diagnostics (IMDX) United States $0.083B 0.00
ImmunoPrecise Antibodies (IPA) Canada $0.076B 0.00
111 (YI) China $0.065B 0.00
P3 Health Partners (PIII) United States $0.045B 0.00
HeartBeam (BEAT) United States $0.043B 0.00
Zhongchao (ZCMD) China $0.028B 0.00
Precipio (PRPO) United States $0.024B 0.00
Streamline Health Solutions (STRM) United States $0.023B 0.00
Bullfrog AI Holdings (BFRG) United States $0.014B 0.00
Strata Skin Sciences (SSKN) United States $0.010B 0.00
Healthcare Triangle (HCTI) United States $0.010B 0.00
MSP Recovery (MSPR) United States $0.009B 0.00
Predictive Oncology (POAI) United States $0.007B 0.00
HeartSciences (HSCS) United States $0.006B 0.00
Movano (MOVE) United States $0.005B 0.00
Tivic Health Systems (TIVC) United States $0.004B 0.00
Evaxion - (EVAX) Denmark $0.004B 0.00
Mobile-health Network Solutions (MNDR) Singapore $0.003B 0.00
Future Health ESG (FHLT) United States $0.000B 0.00